WHITEHOUSE STATION, N.J., April 30 (UPI) -- Merck Research Laboratories says the U.S. Food and Drug Administration has rejected an application for a new cholesterol drug.
The company that makes the drug Erbitux, which treats colorectal, head and neck cancer, has decided to sell the drug in Canada after a two-year wrangle over price.
The Food and Drug Administration was criticized for not doing more checks of foreign drug manufacturers in the wake of problems with the blood thinner heparin and other products.
... study published in BioMed Central's open access Harm Reduction Journal. It found that problem drug-users who were younger, homeless or not currently injecting are significantly more likely to exit ...
... million more in funding and a range of new powers to protect Americans from unsafe drug imports, federal health officials said Tuesday while facing tough questioning from a congressional committee ...
... a generation of young people were urged to "turn on and tune out" with the aid of psychedelic drugs. But at least one hallucinogenic drug remains legal and widely available -- and it's become popular ...
A report has found that, overall, the use of tobacco, alcohol and illicit drugs has dropped since 2004, yet teenagers are still drinking dangerous amounts.
Young women who took the commonly used epilepsy drug phenytoin for one year showed significant bone loss compared to women taking other epilepsy drugs, according to a new study in Neurology.
... have been increasing reports of osteonecrosis (bone death) of the jaw in patients who have been taking the drugs for osteoporosis or for treatment from the bone-wasting effects of cancer. He said he ...
... director of the complications program at JDRF, “These are very encouraging results, showing that drugs we have been testing in human clinical trials can be effective in slowing or stopping the effects ...
... closed containers that might be used to deliver precise micro- or even nano-quantities of drugs. According to ISI project leader Peter Will, who is also a research professor in the Viterbi School of ...
... .”
“We are excited about the success of this work and the prospects it holds for future drug development,” said USAMRIID principal investigator S. Ashraf Ahmed, who initiated the structure-based ...
The key U.S. food and drug regulator has announced a rapid hiring surge to boost its work to protect public health.
... a particular challenge to the subjects’ ability to resist substance use – such as the offer of drugs from a dealer. The narrator of the module then presented different skills and strategies to avoid ...
The companies said that their drug Rituxan did not achieve any of seven measures of effectiveness in a late-stage patient trial.
